Navigating the Clinical Research Process for Mild Cognitive Impairment
ConditionMild Cognitive Impairment
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPower Life Sciences Inc.
About this trial
Participation in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This trial will admit a wide range of data on the clinical trial experience of mild cognitive impairment patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future mild cognitive impairment patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Confirmed diagnosis of mild cognitive impairment
Participant must be 18 years of age or older
Participant must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study.
Disqualifiers
Pregnant or lactating woman
Participant is actively receiving study therapy in another
Inability to provide written informed consent
Trial population
Mild cognitive impairment patients who are actively considering participating in a clinical trial, but have not yet completed enrollment and randomization.
Trial design
Design model
Case-crossover
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Rate of patients who decide to enroll in a mild cognitive impairment clinical research.
Time frame
3 months2
Number of mild cognitive impairment study participants who remain in clinical study until completion.
Time frame
12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: